Environmentally harmful pharmaceuticals cannot be replaced yet RIVM investigates how the impact of pharmaceutical residues on the environment may be reduced.
Off-label use of medicinal products in the European Union Off-label use of medicinal products in the European Union is common, both in primary and in secondary care.
Learn how students can contribute to research from NASA, KNMI, RIVM and WUR The Global Learning and Observation to Benefit the Environment (GLOBE) program in the Netherlands (GLOBE Netherlands) is organising the annual GLOBE day on 21 March .
Age and vaccination history affect immune responses after natural infection with whooping cough Age plays a role in immune responses after a natural infection with Bordetella pertussis, the bacterium that causes the contagious respiratory infection pertussis (whooping cough).
Health effects due to titanium nanoparticles in food and toothpaste cannot be excluded Health effects due to exposure to titanium dioxide nanoparticles via food, food supplements and toothpaste cannot be excluded.
Moderate flu season Last winter season, the duration and severity of the influenza epidemic was moderate compared to previous years.
Support for improving health in all policies The Health in All Policies (HiAP) approach involves multiple policy sectors collaborating for promoting and protecting population’s health and addressing health inequalities.
Assessment of health effects of alternative tobacco products To assess the effects on the health of users of alternative tobacco products, more knowledge is required about the composition of the product, the smoker’s behaviour (such as the amount of cigarett
Chikungunya infections in the Caribbean region Since August 2014, there has been an increase in the number of Chikungunya patients in the Caribbean region. Travellers who visit the region can become infected there.
Dr. Els van Schie new director of Environment and Safety Dr. Els van Schie has been appointed RIVM Director of Environment and Safety as from 1 February 2015. She will succeed Dr. Marcel van Raaij and interim director Dr.